Skip to main content

Table 2 Features of cases treated with EVOH (n = 54)

From: Single institutional experience of peripheral applications of a liquid embolic agent: Ethylene Vinyl Alcohol Copolymer

Indications for treatment (%)

 Primary treatment

44 (81.4%)

 Pre-surgical devascularization

5 (9.2%)

 Palliative or symptomatic relief

5 (9.2%)

Mean volume of EVOH

2.2 ml ± 2.3

Type of EVOH concentration used (%)

 18

13 (24%)

 34

35 (65%)

 Both

6 (11%)

Cases with prior embolization and type of agents used (%)

 No prior treatment

32 (59.2%)

 Onyx

9 (16.6%)

 Coils

5 (9.2%)

 Coils + another agent

5 (9.2%)

   + Onyx

2

   + Thrombin

1

   + Gel foam

1

   + Gel foam & Onyx

1

 Gel foam

1 (1.8%)

 Onyx + n-butyl cyanoacrylate (NBCA)

1 (1.8%)

 Microspheres

1 (1.8%)